nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—peripheral nervous system neoplasm—skin cancer	0.646	1	CtDrD
Alitretinoin—CYP1A2—Imiquimod—skin cancer	0.0508	0.303	CbGbCtD
Alitretinoin—ABCB1—Vismodegib—skin cancer	0.0308	0.183	CbGbCtD
Alitretinoin—CYP1A2—Vemurafenib—skin cancer	0.0278	0.166	CbGbCtD
Alitretinoin—CYP1A2—Dacarbazine—skin cancer	0.0213	0.127	CbGbCtD
Alitretinoin—ABCB1—Dactinomycin—skin cancer	0.0162	0.0964	CbGbCtD
Alitretinoin—CYP1A2—Fluorouracil—skin cancer	0.0125	0.0745	CbGbCtD
Alitretinoin—ABCB1—Docetaxel—skin cancer	0.00835	0.0498	CbGbCtD
Alitretinoin—CRABP2—skin epidermis—skin cancer	0.00429	0.107	CbGeAlD
Alitretinoin—CRABP1—nipple—skin cancer	0.00229	0.0571	CbGeAlD
Alitretinoin—CRABP1—neck—skin cancer	0.00227	0.0565	CbGeAlD
Alitretinoin—CRABP2—nipple—skin cancer	0.00207	0.0517	CbGeAlD
Alitretinoin—RXRG—neck—skin cancer	0.00179	0.0447	CbGeAlD
Alitretinoin—CRABP1—connective tissue—skin cancer	0.00163	0.0405	CbGeAlD
Alitretinoin—RARG—nipple—skin cancer	0.00151	0.0377	CbGeAlD
Alitretinoin—CRABP2—connective tissue—skin cancer	0.00147	0.0366	CbGeAlD
Alitretinoin—CRABP1—skin of body—skin cancer	0.00147	0.0366	CbGeAlD
Alitretinoin—CRABP1—mammalian vulva—skin cancer	0.00134	0.0334	CbGeAlD
Alitretinoin—CRABP2—skin of body—skin cancer	0.00133	0.0331	CbGeAlD
Alitretinoin—CRABP2—mammalian vulva—skin cancer	0.00121	0.0302	CbGeAlD
Alitretinoin—CRABP1—female reproductive system—skin cancer	0.00115	0.0286	CbGeAlD
Alitretinoin—CRABP2—female reproductive system—skin cancer	0.00104	0.0258	CbGeAlD
Alitretinoin—RXRA—female reproductive system—skin cancer	0.00103	0.0257	CbGeAlD
Alitretinoin—RARG—skin of body—skin cancer	0.000969	0.0241	CbGeAlD
Alitretinoin—CRABP1—head—skin cancer	0.000959	0.0239	CbGeAlD
Alitretinoin—RARB—female reproductive system—skin cancer	0.000928	0.0231	CbGeAlD
Alitretinoin—RARG—mammalian vulva—skin cancer	0.000884	0.022	CbGeAlD
Alitretinoin—CRABP2—head—skin cancer	0.000867	0.0216	CbGeAlD
Alitretinoin—RXRA—head—skin cancer	0.000863	0.0215	CbGeAlD
Alitretinoin—RARB—head—skin cancer	0.000775	0.0193	CbGeAlD
Alitretinoin—RXRG—head—skin cancer	0.000758	0.0189	CbGeAlD
Alitretinoin—RARG—female reproductive system—skin cancer	0.000757	0.0188	CbGeAlD
Alitretinoin—RARA—lymphoid tissue—skin cancer	0.000738	0.0184	CbGeAlD
Alitretinoin—RXRB—head—skin cancer	0.000713	0.0177	CbGeAlD
Alitretinoin—RARA—female reproductive system—skin cancer	0.000712	0.0177	CbGeAlD
Alitretinoin—RARG—head—skin cancer	0.000633	0.0157	CbGeAlD
Alitretinoin—RARA—head—skin cancer	0.000595	0.0148	CbGeAlD
Alitretinoin—RARB—lymph node—skin cancer	0.000543	0.0135	CbGeAlD
Alitretinoin—CYP1A2—nipple—skin cancer	0.000528	0.0131	CbGeAlD
Alitretinoin—RARG—lymph node—skin cancer	0.000443	0.011	CbGeAlD
Alitretinoin—RARA—lymph node—skin cancer	0.000416	0.0104	CbGeAlD
Alitretinoin—ABCB1—blood vessel—skin cancer	0.000374	0.00931	CbGeAlD
Alitretinoin—ABCB1—epithelium—skin cancer	0.000182	0.00453	CbGeAlD
Alitretinoin—ABCB1—mammalian vulva—skin cancer	0.000158	0.00393	CbGeAlD
Alitretinoin—ABCB1—lymphoid tissue—skin cancer	0.00014	0.00349	CbGeAlD
Alitretinoin—ABCB1—female reproductive system—skin cancer	0.000135	0.00337	CbGeAlD
Alitretinoin—ABCB1—head—skin cancer	0.000113	0.00281	CbGeAlD
Alitretinoin—Angiopathy—Temozolomide—skin cancer	8.84e-05	0.000607	CcSEcCtD
Alitretinoin—Cough—Bleomycin—skin cancer	8.77e-05	0.000602	CcSEcCtD
Alitretinoin—Chills—Temozolomide—skin cancer	8.74e-05	0.0006	CcSEcCtD
Alitretinoin—Dehydration—Docetaxel—skin cancer	8.71e-05	0.000598	CcSEcCtD
Alitretinoin—Ill-defined disorder—Dactinomycin—skin cancer	8.7e-05	0.000597	CcSEcCtD
Alitretinoin—Anaemia—Dactinomycin—skin cancer	8.67e-05	0.000595	CcSEcCtD
Alitretinoin—Vomiting—Vemurafenib—skin cancer	8.61e-05	0.000591	CcSEcCtD
Alitretinoin—Alopecia—Temozolomide—skin cancer	8.61e-05	0.000591	CcSEcCtD
Alitretinoin—Dry skin—Docetaxel—skin cancer	8.58e-05	0.00059	CcSEcCtD
Alitretinoin—Chest pain—Bleomycin—skin cancer	8.56e-05	0.000588	CcSEcCtD
Alitretinoin—Myalgia—Bleomycin—skin cancer	8.56e-05	0.000588	CcSEcCtD
Alitretinoin—Rash—Vemurafenib—skin cancer	8.54e-05	0.000586	CcSEcCtD
Alitretinoin—Mental disorder—Temozolomide—skin cancer	8.54e-05	0.000586	CcSEcCtD
Alitretinoin—Dermatitis—Vemurafenib—skin cancer	8.53e-05	0.000586	CcSEcCtD
Alitretinoin—Hypersensitivity—Imiquimod—skin cancer	8.51e-05	0.000584	CcSEcCtD
Alitretinoin—Headache—Vemurafenib—skin cancer	8.49e-05	0.000583	CcSEcCtD
Alitretinoin—Erythema—Temozolomide—skin cancer	8.48e-05	0.000582	CcSEcCtD
Alitretinoin—Malnutrition—Temozolomide—skin cancer	8.48e-05	0.000582	CcSEcCtD
Alitretinoin—Discomfort—Bleomycin—skin cancer	8.46e-05	0.000581	CcSEcCtD
Alitretinoin—Malaise—Dactinomycin—skin cancer	8.46e-05	0.000581	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Docetaxel—skin cancer	8.43e-05	0.000579	CcSEcCtD
Alitretinoin—Nasopharyngitis—Docetaxel—skin cancer	8.38e-05	0.000575	CcSEcCtD
Alitretinoin—Asthenia—Imiquimod—skin cancer	8.29e-05	0.000569	CcSEcCtD
Alitretinoin—Confusional state—Bleomycin—skin cancer	8.27e-05	0.000568	CcSEcCtD
Alitretinoin—Anaphylactic shock—Bleomycin—skin cancer	8.21e-05	0.000563	CcSEcCtD
Alitretinoin—Oedema—Bleomycin—skin cancer	8.21e-05	0.000563	CcSEcCtD
Alitretinoin—Back pain—Temozolomide—skin cancer	8.2e-05	0.000563	CcSEcCtD
Alitretinoin—Pruritus—Imiquimod—skin cancer	8.17e-05	0.000561	CcSEcCtD
Alitretinoin—Infection—Bleomycin—skin cancer	8.15e-05	0.00056	CcSEcCtD
Alitretinoin—Dysphagia—Docetaxel—skin cancer	8.09e-05	0.000556	CcSEcCtD
Alitretinoin—Nausea—Vemurafenib—skin cancer	8.05e-05	0.000552	CcSEcCtD
Alitretinoin—Thrombocytopenia—Bleomycin—skin cancer	8.03e-05	0.000552	CcSEcCtD
Alitretinoin—Arrhythmia—Fluorouracil—skin cancer	8.02e-05	0.000551	CcSEcCtD
Alitretinoin—Vision blurred—Temozolomide—skin cancer	7.99e-05	0.000549	CcSEcCtD
Alitretinoin—Myalgia—Dactinomycin—skin cancer	7.98e-05	0.000548	CcSEcCtD
Alitretinoin—Bronchospasm—Docetaxel—skin cancer	7.96e-05	0.000547	CcSEcCtD
Alitretinoin—Tremor—Temozolomide—skin cancer	7.95e-05	0.000546	CcSEcCtD
Alitretinoin—Alopecia—Fluorouracil—skin cancer	7.93e-05	0.000545	CcSEcCtD
Alitretinoin—ABCB1—lymph node—skin cancer	7.91e-05	0.00197	CbGeAlD
Alitretinoin—Diarrhoea—Imiquimod—skin cancer	7.9e-05	0.000543	CcSEcCtD
Alitretinoin—Discomfort—Dactinomycin—skin cancer	7.89e-05	0.000542	CcSEcCtD
Alitretinoin—Ill-defined disorder—Temozolomide—skin cancer	7.87e-05	0.00054	CcSEcCtD
Alitretinoin—Anaemia—Temozolomide—skin cancer	7.84e-05	0.000538	CcSEcCtD
Alitretinoin—Anorexia—Bleomycin—skin cancer	7.82e-05	0.000537	CcSEcCtD
Alitretinoin—Erythema—Fluorouracil—skin cancer	7.81e-05	0.000537	CcSEcCtD
Alitretinoin—Agitation—Temozolomide—skin cancer	7.79e-05	0.000535	CcSEcCtD
Alitretinoin—Hypotension—Bleomycin—skin cancer	7.67e-05	0.000527	CcSEcCtD
Alitretinoin—Oedema—Dactinomycin—skin cancer	7.65e-05	0.000526	CcSEcCtD
Alitretinoin—Malaise—Temozolomide—skin cancer	7.65e-05	0.000525	CcSEcCtD
Alitretinoin—Dizziness—Imiquimod—skin cancer	7.64e-05	0.000525	CcSEcCtD
Alitretinoin—Infection—Dactinomycin—skin cancer	7.6e-05	0.000522	CcSEcCtD
Alitretinoin—Neutropenia—Docetaxel—skin cancer	7.57e-05	0.00052	CcSEcCtD
Alitretinoin—Palpitations—Temozolomide—skin cancer	7.5e-05	0.000515	CcSEcCtD
Alitretinoin—Thrombocytopenia—Dactinomycin—skin cancer	7.49e-05	0.000515	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Bleomycin—skin cancer	7.48e-05	0.000513	CcSEcCtD
Alitretinoin—Cough—Temozolomide—skin cancer	7.4e-05	0.000508	CcSEcCtD
Alitretinoin—Paraesthesia—Bleomycin—skin cancer	7.37e-05	0.000506	CcSEcCtD
Alitretinoin—Weight increased—Docetaxel—skin cancer	7.37e-05	0.000506	CcSEcCtD
Alitretinoin—Vision blurred—Fluorouracil—skin cancer	7.36e-05	0.000506	CcSEcCtD
Alitretinoin—Convulsion—Temozolomide—skin cancer	7.35e-05	0.000505	CcSEcCtD
Alitretinoin—Vomiting—Imiquimod—skin cancer	7.34e-05	0.000504	CcSEcCtD
Alitretinoin—Weight decreased—Docetaxel—skin cancer	7.32e-05	0.000503	CcSEcCtD
Alitretinoin—Hypertension—Temozolomide—skin cancer	7.32e-05	0.000503	CcSEcCtD
Alitretinoin—Dyspnoea—Bleomycin—skin cancer	7.32e-05	0.000502	CcSEcCtD
Alitretinoin—Anorexia—Dactinomycin—skin cancer	7.3e-05	0.000501	CcSEcCtD
Alitretinoin—Rash—Imiquimod—skin cancer	7.28e-05	0.0005	CcSEcCtD
Alitretinoin—Dermatitis—Imiquimod—skin cancer	7.28e-05	0.0005	CcSEcCtD
Alitretinoin—Pneumonia—Docetaxel—skin cancer	7.26e-05	0.000499	CcSEcCtD
Alitretinoin—Headache—Imiquimod—skin cancer	7.24e-05	0.000497	CcSEcCtD
Alitretinoin—Anaemia—Fluorouracil—skin cancer	7.22e-05	0.000496	CcSEcCtD
Alitretinoin—Arthralgia—Temozolomide—skin cancer	7.22e-05	0.000496	CcSEcCtD
Alitretinoin—Myalgia—Temozolomide—skin cancer	7.22e-05	0.000496	CcSEcCtD
Alitretinoin—Infestation—Docetaxel—skin cancer	7.22e-05	0.000496	CcSEcCtD
Alitretinoin—Infestation NOS—Docetaxel—skin cancer	7.22e-05	0.000496	CcSEcCtD
Alitretinoin—Anxiety—Temozolomide—skin cancer	7.2e-05	0.000494	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	7.17e-05	0.000492	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Docetaxel—skin cancer	7.16e-05	0.000491	CcSEcCtD
Alitretinoin—Discomfort—Temozolomide—skin cancer	7.13e-05	0.00049	CcSEcCtD
Alitretinoin—Decreased appetite—Bleomycin—skin cancer	7.13e-05	0.00049	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Docetaxel—skin cancer	7.12e-05	0.000489	CcSEcCtD
Alitretinoin—Renal failure—Docetaxel—skin cancer	7.09e-05	0.000487	CcSEcCtD
Alitretinoin—Myocardial infarction—Docetaxel—skin cancer	7.07e-05	0.000486	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Docetaxel—skin cancer	7.07e-05	0.000486	CcSEcCtD
Alitretinoin—Dry mouth—Temozolomide—skin cancer	7.06e-05	0.000485	CcSEcCtD
Alitretinoin—Stomatitis—Docetaxel—skin cancer	7.04e-05	0.000483	CcSEcCtD
Alitretinoin—Pain—Bleomycin—skin cancer	7.02e-05	0.000482	CcSEcCtD
Alitretinoin—Conjunctivitis—Docetaxel—skin cancer	7.02e-05	0.000482	CcSEcCtD
Alitretinoin—Confusional state—Temozolomide—skin cancer	6.98e-05	0.000479	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Dactinomycin—skin cancer	6.97e-05	0.000479	CcSEcCtD
Alitretinoin—Oedema—Temozolomide—skin cancer	6.92e-05	0.000475	CcSEcCtD
Alitretinoin—Anaphylactic shock—Temozolomide—skin cancer	6.92e-05	0.000475	CcSEcCtD
Alitretinoin—Infection—Temozolomide—skin cancer	6.88e-05	0.000472	CcSEcCtD
Alitretinoin—Nausea—Imiquimod—skin cancer	6.86e-05	0.000471	CcSEcCtD
Alitretinoin—Epistaxis—Docetaxel—skin cancer	6.81e-05	0.000467	CcSEcCtD
Alitretinoin—Nervous system disorder—Temozolomide—skin cancer	6.79e-05	0.000466	CcSEcCtD
Alitretinoin—Thrombocytopenia—Temozolomide—skin cancer	6.78e-05	0.000465	CcSEcCtD
Alitretinoin—Convulsion—Fluorouracil—skin cancer	6.77e-05	0.000465	CcSEcCtD
Alitretinoin—Feeling abnormal—Bleomycin—skin cancer	6.76e-05	0.000464	CcSEcCtD
Alitretinoin—Agranulocytosis—Docetaxel—skin cancer	6.74e-05	0.000463	CcSEcCtD
Alitretinoin—Skin disorder—Temozolomide—skin cancer	6.72e-05	0.000462	CcSEcCtD
Alitretinoin—Hyperhidrosis—Temozolomide—skin cancer	6.69e-05	0.00046	CcSEcCtD
Alitretinoin—Myalgia—Fluorouracil—skin cancer	6.65e-05	0.000457	CcSEcCtD
Alitretinoin—Chest pain—Fluorouracil—skin cancer	6.65e-05	0.000457	CcSEcCtD
Alitretinoin—Decreased appetite—Dactinomycin—skin cancer	6.65e-05	0.000457	CcSEcCtD
Alitretinoin—Fatigue—Dactinomycin—skin cancer	6.6e-05	0.000453	CcSEcCtD
Alitretinoin—Anorexia—Temozolomide—skin cancer	6.6e-05	0.000453	CcSEcCtD
Alitretinoin—Discomfort—Fluorouracil—skin cancer	6.57e-05	0.000451	CcSEcCtD
Alitretinoin—Pain—Dactinomycin—skin cancer	6.54e-05	0.000449	CcSEcCtD
Alitretinoin—Urticaria—Bleomycin—skin cancer	6.52e-05	0.000448	CcSEcCtD
Alitretinoin—Haemoglobin—Docetaxel—skin cancer	6.51e-05	0.000447	CcSEcCtD
Alitretinoin—Body temperature increased—Bleomycin—skin cancer	6.49e-05	0.000445	CcSEcCtD
Alitretinoin—Haemorrhage—Docetaxel—skin cancer	6.48e-05	0.000445	CcSEcCtD
Alitretinoin—Hepatitis—Docetaxel—skin cancer	6.48e-05	0.000445	CcSEcCtD
Alitretinoin—Hypoaesthesia—Docetaxel—skin cancer	6.45e-05	0.000443	CcSEcCtD
Alitretinoin—Confusional state—Fluorouracil—skin cancer	6.43e-05	0.000442	CcSEcCtD
Alitretinoin—Pharyngitis—Docetaxel—skin cancer	6.43e-05	0.000442	CcSEcCtD
Alitretinoin—Urinary tract disorder—Docetaxel—skin cancer	6.4e-05	0.000439	CcSEcCtD
Alitretinoin—Oedema peripheral—Docetaxel—skin cancer	6.38e-05	0.000438	CcSEcCtD
Alitretinoin—Anaphylactic shock—Fluorouracil—skin cancer	6.38e-05	0.000438	CcSEcCtD
Alitretinoin—Oedema—Fluorouracil—skin cancer	6.38e-05	0.000438	CcSEcCtD
Alitretinoin—Urethral disorder—Docetaxel—skin cancer	6.35e-05	0.000436	CcSEcCtD
Alitretinoin—Infection—Fluorouracil—skin cancer	6.34e-05	0.000435	CcSEcCtD
Alitretinoin—Feeling abnormal—Dactinomycin—skin cancer	6.31e-05	0.000433	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Temozolomide—skin cancer	6.31e-05	0.000433	CcSEcCtD
Alitretinoin—Insomnia—Temozolomide—skin cancer	6.26e-05	0.00043	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Dactinomycin—skin cancer	6.26e-05	0.00043	CcSEcCtD
Alitretinoin—Nervous system disorder—Fluorouracil—skin cancer	6.25e-05	0.000429	CcSEcCtD
Alitretinoin—Thrombocytopenia—Fluorouracil—skin cancer	6.24e-05	0.000429	CcSEcCtD
Alitretinoin—Visual impairment—Docetaxel—skin cancer	6.24e-05	0.000429	CcSEcCtD
Alitretinoin—Tachycardia—Fluorouracil—skin cancer	6.22e-05	0.000427	CcSEcCtD
Alitretinoin—Paraesthesia—Temozolomide—skin cancer	6.22e-05	0.000427	CcSEcCtD
Alitretinoin—Dyspnoea—Temozolomide—skin cancer	6.17e-05	0.000424	CcSEcCtD
Alitretinoin—Somnolence—Temozolomide—skin cancer	6.15e-05	0.000423	CcSEcCtD
Alitretinoin—Erythema multiforme—Docetaxel—skin cancer	6.13e-05	0.000421	CcSEcCtD
Alitretinoin—Dyspepsia—Temozolomide—skin cancer	6.09e-05	0.000418	CcSEcCtD
Alitretinoin—Anorexia—Fluorouracil—skin cancer	6.08e-05	0.000417	CcSEcCtD
Alitretinoin—Eye disorder—Docetaxel—skin cancer	6.06e-05	0.000416	CcSEcCtD
Alitretinoin—Abdominal pain—Dactinomycin—skin cancer	6.05e-05	0.000415	CcSEcCtD
Alitretinoin—Body temperature increased—Dactinomycin—skin cancer	6.05e-05	0.000415	CcSEcCtD
Alitretinoin—Hypersensitivity—Bleomycin—skin cancer	6.05e-05	0.000415	CcSEcCtD
Alitretinoin—Decreased appetite—Temozolomide—skin cancer	6.02e-05	0.000413	CcSEcCtD
Alitretinoin—Flushing—Docetaxel—skin cancer	6.01e-05	0.000413	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Temozolomide—skin cancer	5.98e-05	0.00041	CcSEcCtD
Alitretinoin—Fatigue—Temozolomide—skin cancer	5.97e-05	0.00041	CcSEcCtD
Alitretinoin—Hypotension—Fluorouracil—skin cancer	5.96e-05	0.000409	CcSEcCtD
Alitretinoin—Constipation—Temozolomide—skin cancer	5.92e-05	0.000406	CcSEcCtD
Alitretinoin—Pain—Temozolomide—skin cancer	5.92e-05	0.000406	CcSEcCtD
Alitretinoin—Asthenia—Bleomycin—skin cancer	5.89e-05	0.000404	CcSEcCtD
Alitretinoin—Angiopathy—Docetaxel—skin cancer	5.88e-05	0.000404	CcSEcCtD
Alitretinoin—Chills—Docetaxel—skin cancer	5.81e-05	0.000399	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Fluorouracil—skin cancer	5.81e-05	0.000399	CcSEcCtD
Alitretinoin—Pruritus—Bleomycin—skin cancer	5.81e-05	0.000399	CcSEcCtD
Alitretinoin—Arrhythmia—Docetaxel—skin cancer	5.79e-05	0.000397	CcSEcCtD
Alitretinoin—Insomnia—Fluorouracil—skin cancer	5.77e-05	0.000396	CcSEcCtD
Alitretinoin—Paraesthesia—Fluorouracil—skin cancer	5.73e-05	0.000393	CcSEcCtD
Alitretinoin—Alopecia—Docetaxel—skin cancer	5.73e-05	0.000393	CcSEcCtD
Alitretinoin—Feeling abnormal—Temozolomide—skin cancer	5.7e-05	0.000392	CcSEcCtD
Alitretinoin—Dyspnoea—Fluorouracil—skin cancer	5.69e-05	0.00039	CcSEcCtD
Alitretinoin—Mental disorder—Docetaxel—skin cancer	5.68e-05	0.00039	CcSEcCtD
Alitretinoin—Somnolence—Fluorouracil—skin cancer	5.67e-05	0.000389	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Temozolomide—skin cancer	5.66e-05	0.000389	CcSEcCtD
Alitretinoin—Erythema—Docetaxel—skin cancer	5.64e-05	0.000387	CcSEcCtD
Alitretinoin—Malnutrition—Docetaxel—skin cancer	5.64e-05	0.000387	CcSEcCtD
Alitretinoin—Hypersensitivity—Dactinomycin—skin cancer	5.64e-05	0.000387	CcSEcCtD
Alitretinoin—Dyspepsia—Fluorouracil—skin cancer	5.61e-05	0.000386	CcSEcCtD
Alitretinoin—Decreased appetite—Fluorouracil—skin cancer	5.54e-05	0.000381	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Fluorouracil—skin cancer	5.51e-05	0.000378	CcSEcCtD
Alitretinoin—Urticaria—Temozolomide—skin cancer	5.5e-05	0.000378	CcSEcCtD
Alitretinoin—Asthenia—Dactinomycin—skin cancer	5.49e-05	0.000377	CcSEcCtD
Alitretinoin—Abdominal pain—Temozolomide—skin cancer	5.47e-05	0.000376	CcSEcCtD
Alitretinoin—Body temperature increased—Temozolomide—skin cancer	5.47e-05	0.000376	CcSEcCtD
Alitretinoin—Back pain—Docetaxel—skin cancer	5.46e-05	0.000375	CcSEcCtD
Alitretinoin—Pain—Fluorouracil—skin cancer	5.45e-05	0.000375	CcSEcCtD
Alitretinoin—Feeling abnormal—Fluorouracil—skin cancer	5.26e-05	0.000361	CcSEcCtD
Alitretinoin—Diarrhoea—Dactinomycin—skin cancer	5.24e-05	0.00036	CcSEcCtD
Alitretinoin—Vomiting—Bleomycin—skin cancer	5.22e-05	0.000358	CcSEcCtD
Alitretinoin—Anaemia—Docetaxel—skin cancer	5.21e-05	0.000358	CcSEcCtD
Alitretinoin—Rash—Bleomycin—skin cancer	5.17e-05	0.000355	CcSEcCtD
Alitretinoin—Dermatitis—Bleomycin—skin cancer	5.17e-05	0.000355	CcSEcCtD
Alitretinoin—Hypersensitivity—Temozolomide—skin cancer	5.1e-05	0.00035	CcSEcCtD
Alitretinoin—Urticaria—Fluorouracil—skin cancer	5.07e-05	0.000348	CcSEcCtD
Alitretinoin—Syncope—Docetaxel—skin cancer	5.06e-05	0.000347	CcSEcCtD
Alitretinoin—Body temperature increased—Fluorouracil—skin cancer	5.04e-05	0.000346	CcSEcCtD
Alitretinoin—Palpitations—Docetaxel—skin cancer	4.98e-05	0.000342	CcSEcCtD
Alitretinoin—Asthenia—Temozolomide—skin cancer	4.97e-05	0.000341	CcSEcCtD
Alitretinoin—Loss of consciousness—Docetaxel—skin cancer	4.96e-05	0.00034	CcSEcCtD
Alitretinoin—Cough—Docetaxel—skin cancer	4.92e-05	0.000338	CcSEcCtD
Alitretinoin—Pruritus—Temozolomide—skin cancer	4.9e-05	0.000336	CcSEcCtD
Alitretinoin—Convulsion—Docetaxel—skin cancer	4.89e-05	0.000336	CcSEcCtD
Alitretinoin—Nausea—Bleomycin—skin cancer	4.87e-05	0.000335	CcSEcCtD
Alitretinoin—Hypertension—Docetaxel—skin cancer	4.87e-05	0.000334	CcSEcCtD
Alitretinoin—Vomiting—Dactinomycin—skin cancer	4.87e-05	0.000334	CcSEcCtD
Alitretinoin—Rash—Dactinomycin—skin cancer	4.83e-05	0.000331	CcSEcCtD
Alitretinoin—Chest pain—Docetaxel—skin cancer	4.8e-05	0.00033	CcSEcCtD
Alitretinoin—Myalgia—Docetaxel—skin cancer	4.8e-05	0.00033	CcSEcCtD
Alitretinoin—Arthralgia—Docetaxel—skin cancer	4.8e-05	0.00033	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	4.77e-05	0.000327	CcSEcCtD
Alitretinoin—Diarrhoea—Temozolomide—skin cancer	4.74e-05	0.000325	CcSEcCtD
Alitretinoin—Hypersensitivity—Fluorouracil—skin cancer	4.7e-05	0.000323	CcSEcCtD
Alitretinoin—Dry mouth—Docetaxel—skin cancer	4.7e-05	0.000322	CcSEcCtD
Alitretinoin—Confusional state—Docetaxel—skin cancer	4.64e-05	0.000319	CcSEcCtD
Alitretinoin—Oedema—Docetaxel—skin cancer	4.6e-05	0.000316	CcSEcCtD
Alitretinoin—Anaphylactic shock—Docetaxel—skin cancer	4.6e-05	0.000316	CcSEcCtD
Alitretinoin—Dizziness—Temozolomide—skin cancer	4.58e-05	0.000314	CcSEcCtD
Alitretinoin—Infection—Docetaxel—skin cancer	4.57e-05	0.000314	CcSEcCtD
Alitretinoin—Nausea—Dactinomycin—skin cancer	4.55e-05	0.000312	CcSEcCtD
Alitretinoin—Shock—Docetaxel—skin cancer	4.53e-05	0.000311	CcSEcCtD
Alitretinoin—Nervous system disorder—Docetaxel—skin cancer	4.51e-05	0.00031	CcSEcCtD
Alitretinoin—Pruritus—Fluorouracil—skin cancer	4.51e-05	0.00031	CcSEcCtD
Alitretinoin—Thrombocytopenia—Docetaxel—skin cancer	4.51e-05	0.000309	CcSEcCtD
Alitretinoin—Tachycardia—Docetaxel—skin cancer	4.49e-05	0.000309	CcSEcCtD
Alitretinoin—Skin disorder—Docetaxel—skin cancer	4.47e-05	0.000307	CcSEcCtD
Alitretinoin—Vomiting—Temozolomide—skin cancer	4.4e-05	0.000302	CcSEcCtD
Alitretinoin—Anorexia—Docetaxel—skin cancer	4.39e-05	0.000301	CcSEcCtD
Alitretinoin—Rash—Temozolomide—skin cancer	4.36e-05	0.0003	CcSEcCtD
Alitretinoin—Diarrhoea—Fluorouracil—skin cancer	4.36e-05	0.0003	CcSEcCtD
Alitretinoin—Dermatitis—Temozolomide—skin cancer	4.36e-05	0.000299	CcSEcCtD
Alitretinoin—Headache—Temozolomide—skin cancer	4.34e-05	0.000298	CcSEcCtD
Alitretinoin—Hypotension—Docetaxel—skin cancer	4.3e-05	0.000295	CcSEcCtD
Alitretinoin—Dizziness—Fluorouracil—skin cancer	4.22e-05	0.00029	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Docetaxel—skin cancer	4.19e-05	0.000288	CcSEcCtD
Alitretinoin—Insomnia—Docetaxel—skin cancer	4.16e-05	0.000286	CcSEcCtD
Alitretinoin—Paraesthesia—Docetaxel—skin cancer	4.13e-05	0.000284	CcSEcCtD
Alitretinoin—Nausea—Temozolomide—skin cancer	4.11e-05	0.000282	CcSEcCtD
Alitretinoin—Dyspnoea—Docetaxel—skin cancer	4.1e-05	0.000282	CcSEcCtD
Alitretinoin—Somnolence—Docetaxel—skin cancer	4.09e-05	0.000281	CcSEcCtD
Alitretinoin—Vomiting—Fluorouracil—skin cancer	4.06e-05	0.000278	CcSEcCtD
Alitretinoin—Dyspepsia—Docetaxel—skin cancer	4.05e-05	0.000278	CcSEcCtD
Alitretinoin—Rash—Fluorouracil—skin cancer	4.02e-05	0.000276	CcSEcCtD
Alitretinoin—Dermatitis—Fluorouracil—skin cancer	4.02e-05	0.000276	CcSEcCtD
Alitretinoin—Decreased appetite—Docetaxel—skin cancer	4e-05	0.000275	CcSEcCtD
Alitretinoin—Headache—Fluorouracil—skin cancer	4e-05	0.000274	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Docetaxel—skin cancer	3.97e-05	0.000273	CcSEcCtD
Alitretinoin—Fatigue—Docetaxel—skin cancer	3.97e-05	0.000273	CcSEcCtD
Alitretinoin—Pain—Docetaxel—skin cancer	3.94e-05	0.00027	CcSEcCtD
Alitretinoin—Constipation—Docetaxel—skin cancer	3.94e-05	0.00027	CcSEcCtD
Alitretinoin—Feeling abnormal—Docetaxel—skin cancer	3.79e-05	0.00026	CcSEcCtD
Alitretinoin—Nausea—Fluorouracil—skin cancer	3.79e-05	0.00026	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Docetaxel—skin cancer	3.76e-05	0.000258	CcSEcCtD
Alitretinoin—Abdominal pain—Docetaxel—skin cancer	3.64e-05	0.00025	CcSEcCtD
Alitretinoin—Body temperature increased—Docetaxel—skin cancer	3.64e-05	0.00025	CcSEcCtD
Alitretinoin—Hypersensitivity—Docetaxel—skin cancer	3.39e-05	0.000233	CcSEcCtD
Alitretinoin—Asthenia—Docetaxel—skin cancer	3.3e-05	0.000227	CcSEcCtD
Alitretinoin—Pruritus—Docetaxel—skin cancer	3.26e-05	0.000224	CcSEcCtD
Alitretinoin—Diarrhoea—Docetaxel—skin cancer	3.15e-05	0.000216	CcSEcCtD
Alitretinoin—Dizziness—Docetaxel—skin cancer	3.04e-05	0.000209	CcSEcCtD
Alitretinoin—Vomiting—Docetaxel—skin cancer	2.93e-05	0.000201	CcSEcCtD
Alitretinoin—Rash—Docetaxel—skin cancer	2.9e-05	0.000199	CcSEcCtD
Alitretinoin—Dermatitis—Docetaxel—skin cancer	2.9e-05	0.000199	CcSEcCtD
Alitretinoin—Headache—Docetaxel—skin cancer	2.88e-05	0.000198	CcSEcCtD
Alitretinoin—Nausea—Docetaxel—skin cancer	2.73e-05	0.000188	CcSEcCtD
